Ryman Healthcare Limited (RHCGF) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Thank you for standing by and welcome to Ryman Healthcare four-year results briefing. All participants are in listen-only mode. There will be a presentation followed by a question and answer session. If you wish to ask a question, you will need to press the star key followed by the number one on your telephone keypad. I would now like to hand the conference over to Ms. Naomi James, Chief Executive Officer. Please go ahead. Welcome, everyone, and thank you for joining us for our FY25 full year results. With me today, I have Rob Woodgate, our CFO, and Hayden Strickett, our Head of Investor Relations. Starting with slide two, we have a lot to get through today, and we'll try and do that in around 30 minutes or so to allow another 30 minutes for Q&A before we wrap up at midday. Looking at the agenda, there is effectively three parts to the presentation. The first part is focused on how our business is performing across sales, operations and developments. The second part is more backward looking, as Rob takes you through the changes we have made in our financial reporting. And we will finish up on our transformation. Updating you on the strategic priorities we communicated at the equity raise and where we are heading from here. Jumping into the highlights section and moving to slide four. The reset of Ryman started well before I started as CEO in November last year. And a lot has already been achieved. We reset our DMF on new contracts in October last year, which delivers a step change in us for long-term business value. We have seen improved sales momentum since the time of the February equity raise. Our operational reset is well underway, with $23 million in cost removed in the second half of FY25, and we are targeting to double this by the end of the financial year. We...